Autopsy report · NCT03887793

Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination in Integrated Healthcare Delivery Systems

“Inadequate recruitment of study clinics”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

University of North Carolina, Chapel Hill

Sponsor type

University, hospital or other

Conditions

Human Papillomavirus Infection

Interventions

VACs

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome
  “Poor study patient recruitment” (80% match in meaning)
• Efficacy of EndoClot™ Spraying After Endoscopic Resection of Large Colorectal Polyps
  “insufficient recruitment of study patients” (80% match in meaning)
• Brachytherapy Radiation Directly to the Liver in Breast Cancer Patients With Metastatic to Liver
  “Lack of study patients” (76% match in meaning)
• Calcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent Females
  “Poor recruitment to the study” (75% match in meaning)
• Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
  “Study stopped due to difficulties in patient recruitment” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.